Targeting brain inflammation related to seizures
Exploiting EP2 receptor biology to target seizure-related neuroinflammation selectively
This study is looking at how inflammation in the brain after seizures can cause problems later on, and it’s exploring how certain receptors might help or hurt brain cells involved in this process, with the hope of finding new ways to stop epilepsy from developing after a seizure.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10813727 on NIH RePORTER |
What this research studies
This research investigates how inflammation in the brain after seizures can lead to long-term negative effects. It focuses on the role of specific receptors (EP2) that may have opposing effects on brain cells involved in inflammation. By using advanced techniques, the researchers aim to selectively block or activate these receptors in neurons and immune cells to understand their roles better. The goal is to find new ways to prevent epilepsy development following seizures.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced status epilepticus or other severe seizures.
Not a fit: Patients who have not experienced seizures or have other unrelated neurological conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent the development of epilepsy after seizures.
How similar studies have performed: Previous research has shown promising results in targeting neuroinflammation in seizure-related conditions, suggesting potential for success in this approach.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Varvel, Nicholas — Emory University
- Study coordinator: Varvel, Nicholas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.